botulinum toxin type A
Clinical and Laryngotracheoscopic Evaluation of Children with Cerebral Palsy Using Intraparotid Injections of Botulinum Toxin Type A for Drooling Control
... Botulinum toxin type A is a product of biological origin obtained from the anaerobic bacterium Clostridium botulinum ...This toxin binds to the presynaptic region of the motor end ...
8
Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study
... the botulinum toxin type A and placebo groups for baseline demographic characteristics and migraine outcome measures (frequency, duration, and number of moderate and severe attacks, and the number of ...
6
Botulinum Toxin Type A Injection for Management of Upper Limb Spasticity in Children with Cerebral Palsy: a Literature Review
... The aim of this article was to present a review of the research literature on the outcome of botulinum toxin type A (BTX-A) injection for management of upper limb spasticity in children with cerebral ...
15
Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: A review of the science, the clinical data, and patient satisfaction
... all botulinum toxins approved in the United States, the use of these substances worldwide in facial aes- thetics is associated with a remarkable record of safety and tolerability when used as indicated by fully ...
18
Botulinum toxin type A products are not interchangeable: a review of the evidence
... Abstract: Botulinum toxin type A (BoNTA) products are injectable biologic medications derived from Clostridium botulinum bacteria. Several different BoNTA products are marketed in various ...
15
The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache
... to temporomandibular joint dysfunction and tension-type headache. Patients were recruited from the Department of Dental Prosthetics at the Jagiellonian University in Krakow during the years 2009–2014 and were ...
6
Botulinum toxin type A in the treatment of patients with cervical dystonia
... musculature. Botulinum toxin type A is a safe and effective treatment of this disabling and often painful ...of botulinum toxin type A are available worldwide to treat patients ...
8
Botulinum toxin type A treatment to the upper face: retrospective analysis of daily practice
... of botulinum toxin type A preparations in daily clinical practice, analyzed subject and physician satisfaction, the time interval between doses admin- istered (duration between treatment cycles), ...
6
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
... Background: In the majority of cases, trigeminal neuralgia (TN) is a unilateral condition with ultra-short stabbing pain located along one or more branches of the trigeminal nerve. Although prophylactic pharmacological ...
6
Botulinum toxin type A for the management of glabellar rhytids
... used, botulinum toxin type A is effective for the improvement of glabellar rhytids and with little incidence of ...multiple botulinum toxin type A products that are commercially ...
9
STRESS HORMONES IN CHRONIC MIGRAINE ARE MODULATED BY BOTULINUM TOXIN -TYPE A
... In order to increase personal well-being investigate potential natural preventive measures, the aim of the present research was to study hypothalamus-pituitary- adrenal (HPA) axis activity in patients severely affected ...
9
Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?
... against botulinum toxin type ...conventional botulinum toxin may develop neutralizing antibodies, leading to antibody-induced therapy ...of botulinum toxin type A ...
8
Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A
... The baseline visit is undertaken within 2 weeks of the screening visit by a study therapist or clinical research associate. The inclusion/exclusion criteria are reviewed to ensure that the participant is still eligible. ...
11
Efficacy of Botulinum Toxin Type A in Trigeminal Neuralgia in a South Asian Cohort.
... 28. Silberstein SD, Stark SR, Lucas SM, Christie SN, Degryse RE, Turkel CC, et al. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: A randomized, double‑blind, ...
6
Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A
... of botulinum toxin type A are generally mild and ...of toxin spread to nearby ...of botulinum toxin type A in the treatment of participants with upper limb spasticity post ...
11
Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review
... Trigeminal neuralgia is a common disorder caused mainly by compression of the trigeminal nerve root by an overlying blood vessel. Pharmacotherapy and surgery are ineffective or unsuitable in many patients. Therefore, ...
8
Botulinum toxin type A in the management of headache: a review of the literature and personal experience
... [42]. Botulinum toxin type A treatment has been shown to relieve pain associated with the muscle hyperac- tivity characteristic of cervical dystonia and spasticity [43–46] without vascular or ...
8
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
... of botulinum toxin type A, and will review the available randomized, placebo-controlled trials that have looked at its efficacy as a migraine ...
14
Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A
... pain. Botulinum toxin is considered first-line therapy in the treatment of pain and abnormal head posturing associated with cervical ...three botulinum toxin type A neurotoxins and one ...
7
Botulinum toxin type A (BTX-A) to improve the treatment of keloid and hypertrophic scars: A double-blinded randomized clinical trial
... All the patients enrolled in this study are 15-60 years old, referred to Skin Department of Imam Reza Hospital in Tehran (Iran) from November 2016 to November 2017, and suffered from skin scars. Primary history obtained ...
5